CXCR2 and neoplasm: The importance of chemokines in promoting the anti-tumor phenotype is supported by the finding that PyMT-CXCR2−/− neutrophils exhibit reduced tumor killing activity with concomitant increased pro-tumor activities compared to PyMT-CXCR2+/+ neutrophils [69].